{
  "id": 12238287,
  "title": "Standard Biotools Agrees To Sell Microfluidics Business To ARCHIMED",
  "url": "https://urgent.news/2026/10/05/standard-biotools-agrees-to-sell-microfluidics-business-to-archimed",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-05T21:04:04.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/standard-biotools-agrees-sell-microfluidics-business-archimed"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - On Monday, Standard BioTools Inc. (NASDAQ: LAB) announced that it has signed a definitive agreement to sell its Microfluidics business to ARCHIMED, an investment firm focused on the healthcare industry.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}